Financhill
Back

enVVeno Medical Quote, Financials, Valuation and Earnings

Sell
45

NVNO
enVVeno Medical

Last Price:
4.70
Seasonality Move:
41.76%

7 Day Trial

ALL ACCESS PASS

$ 7

enVVeno Medical Price Quote

$4.70

enVVeno Medical Key Stats

Sell
45
enVVeno Medical (NVNO) is a Sell

Day range:
$4.70 - $4.89
52-week range:
$2.61 - $6.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
339.98
P/B ratio:
1.48%

Volume:
30.2K
Avg. volume:
37.7K
1-year change:
62.07%
Market cap:
$62.7M
Revenue:
$0
EPS:
$-1.66

How Much Does enVVeno Medical Make?

Data Unavailable

Is enVVeno Medical Growing As A Company?

Data Unavailable

enVVeno Medical Stock Price Performance

  • Did enVVeno Medical Stock Go Up Last Month?
    enVVeno Medical share price went down by -5.81% last month
  • Did NVNO's Share Price Rise Over The Last Year?
    NVNO share price rose by 62.07% over the past 1 year

What Is enVVeno Medical 52-Week High & Low?

enVVeno Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy enVVeno Medical?

  • How Much Debt Does enVVeno Medical Have?
    Total long term debt quarterly is $0
  • How Much Cash Does enVVeno Medical Have?
    Cash and short term investments quarterly total is $42.9M
  • What Is enVVeno Medical’s Book Value Per Share?
    Book value per share is 3.18

Is enVVeno Medical Cash Flow Positive?

  • What Is NVNO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.3M
  • What Is enVVeno Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is enVVeno Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$8.5M

enVVeno Medical Return On Invested Capital

Data Unavailable

enVVeno Medical Earnings Date & Stock Price

enVVeno Medical Competitors

  • Who Are enVVeno Medical's Competitors?
    Below is a list of companies who compete with enVVeno Medical or are related in some way:
    • Align Technology Inc (ALGN)
    • NeuroOne Medical Technologies Corp (NMTC)
    • Nutriband Inc (NTRB)
    • SINTX Technologies Inc (SINT)
    • ThermoGenesis Holdings Inc (THMO)

enVVeno Medical Dividend Yield

Data Unavailable

enVVeno Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 22.5%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.40
Upside from Last Price: 334.04%

Major Shareholders

  • How many NVNO shares are owned by institutional investors?
    4.3M NVNO shares are owned by institutional investors
  • How many NVNO shares are owned by insiders?
    1.2M NVNO shares are owned by insiders